 Cortexyme, Inc. NASDAQ:CRTX Director David Lamond acquired 49,125 shares of Cortexyme stock in a transaction that occurred on Thursday, June 4th. The stock was acquired at an average cost of 41.73 per share, for a total transaction of 2,049,986.25. Following the purchase, the director now owns 301,829 shares of the companys stock, valued at 12,595,324.17. ... 